Medicare Enrolled

Dr. Ajay Wakhloo, M.D.

Radiation Oncology · Worcester, MA
55 LAKE AVE N, Worcester, MA 01655
5083342776
Registered in NPPES since 2006
NPI: 1174559892 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wakhloo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wakhloo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wakhloo

Dr. Ajay Wakhloo is a radiation oncology specialist in Worcester, MA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Wakhloo received a total of $1,720,892 from 16 pharmaceutical and/or device companies across 1106 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wakhloo is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $1,720,892 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,720,892
Total received (2018-2024)
Avg $245,842/year across 7 years
Top 1% in MA for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
1,106
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$144,304
2023
$212,710
2022
$264,979
2021
$242,593
2020
$183,248
2019
$419,450
2018
$253,609

Payments by company (2024)

Stryker Corporation
$103,149
Medtronic, Inc.
$18,578
Medical Device Business Services, Inc.
$9,930
Philips North America LLC
$8,657
Integer Holdings Corporation
$3,900
InspireMD Ltd
$90
Top 3 companies account for 91.2% of 2024 payments
All-time payments by company (2018-2024) ›
Stryker Corporation
$1,211,428
Medical Device Business Services, Inc.
$147,198
Medtronic, Inc.
$134,354
Medtronic Vascular, Inc.
$122,958
Medtronic USA, Inc.
$82,026
Philips North America LLC
$8,657
Philips Electronics North America Corporation
$8,647
Integer Holdings Corporation
$3,900
MicroVention, Inc.
$746
QAPEL MEDICAL INC
$289
DePuy Synthes Sales Inc.
$257
Penumbra, Inc.
$142
Imperative Care, Inc
$96
InspireMD Ltd
$90
Biosense Webster, Inc.
$70
Olympus America Inc.
$32
Top 3 companies account for 86.8% of all-time payments
Associated products mentioned in payments ›
(0073) IGT Enabling functio · (3597) RS Car Vasc Udivided · (8305) Azurion 7 B12 · (8334) IGT_D Peripheral · (9547) IGT Systems Undivided · 1488 · 1688 · AVS ANCHOR-C · AXERT · AXIUM PRIMETM · AXS CATALYST 7 · Avigo · Axium · CATALYST · CEREPAK UNIFORM · CGuard · CITADEL · CUB · Catheter · Covidien-Access · Covidien-Intrasaccular · DELTAPAQ CERECYTE · EMBOGUARD · EMBOTRAP II Revascularization Device · EVOLVE · EVOLVE PROLINE · EXCELSIOR SL-10 · Embotrap · Enterprise 2 · FLOWGATE · IDEAL EYES · INFINITY · KYPHON Balloon Kyphoplasty · NA · NEURO · NEUROFORM ATLAS · NEUROFORM EZ · NEUROMEND · NEW PRODUCT DEVELOPMENT · NONE · ONYX 18 · PIPELINE · POSITIONPRO · PULSERIDER · Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device · RED 72 · RIST · Rist-5F · STENT · SURPASS · SURPASS EVOLVE · SYNCHRO · SYNCHRO SELECT · Solitaire · TARGET · TREVO · TRUFILL · UNIVERSAL NEURO 3 · VenaSeal · WEB · XIA 3 · ZOOM REPERFUSION CATHETER
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a radiation oncology specialist in Worcester?
Compare radiation oncologists in the Worcester area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wakhloo is a radiation oncology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Wakhloo receive payments from pharmaceutical companies?
Yes. Dr. Wakhloo received a total of $1,720,892 from 16 companies across 1,106 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Wakhloo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →